These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25676888)

  • 21. Variable omeprazole kinetics in healthy Jordanian adults.
    Albsoul-Younes A; Tayyem R; Najib N
    Biopharm Drug Dispos; 2005 Jul; 26(5):183-8. PubMed ID: 15906422
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Omeprazole absorption from a compounded transdermal formulation in healthy volunteers.
    Haas CE; Lin L; Cloen D; Kufel T; Moon R; Frerichs V
    J Am Pharm Assoc (2003); 2005; 45(4):473-8. PubMed ID: 16128503
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Higher AUCs on oral administration of omeprazole and felodipine in Indian volunteers--are they clinically important?
    Joseph T; Gowrishankar R
    Indian J Physiol Pharmacol; 1996 Jul; 40(3):253-6. PubMed ID: 8950143
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of omeprazole in rats with water deprivation for 72 hours.
    Lee DY; Shin HS; Lee I; Lee MG
    Biopharm Drug Dispos; 2006 Nov; 27(8):361-70. PubMed ID: 16894645
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic and pharmacodynamic alterations in the Roux-en-Y gastric bypass recipients.
    Tandra S; Chalasani N; Jones DR; Mattar S; Hall SD; Vuppalanchi R
    Ann Surg; 2013 Aug; 258(2):262-9. PubMed ID: 23222033
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intragastric acidity and omeprazole exposure during dosing with either PA32540 (enteric-coated aspirin 325 mg + immediate-release omeprazole 40 mg) or enteric-coated aspirin 325 mg + enteric-coated omeprazole 40 mg - a randomised, phase 1, crossover study.
    Miner PB; Fort JG; Zhang Y
    Aliment Pharmacol Ther; 2013 Jul; 38(1):62-71. PubMed ID: 23692061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of orally administered enteric-coated omeprazole on gastric acid secretion in horses.
    Andrews FM; Doherty TJ; Blackford JT; Nadeau JA; Saxton AM
    Am J Vet Res; 1999 Aug; 60(8):929-31. PubMed ID: 10451198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of orally administered omeprazole in children. International Pediatric Omeprazole Pharmacokinetic Group.
    Andersson T; Hassall E; Lundborg P; Shepherd R; Radke M; Marcon M; Dalväg A; Martin S; Behrens R; Koletzko S; Becker M; Drouin E; Göthberg G
    Am J Gastroenterol; 2000 Nov; 95(11):3101-6. PubMed ID: 11095324
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetics and tolerability of a new formulation of omeprazole in the horse.
    Di Salvo A; Busechian S; Zappulla F; Marchesi MC; Pieramati C; Orvieto S; Boveri M; Predieri PG; Rueca F; Della Rocca G
    J Vet Pharmacol Ther; 2017 Aug; 40(4):348-355. PubMed ID: 27885694
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bioequivalence of two enteric coated formulations of pantoprazole in healthy volunteers under fasting and fed conditions.
    de Campos DR; Vieira NR; Bernasconi G; Barros FA; Meurer EC; Marchioretto MA; Coelho EC; Calafatti SA; Sommer C; Couto JM; Buranello S; Silva AR; Amarante AR; Abib E; Júnior JP
    Arzneimittelforschung; 2007; 57(6):309-14. PubMed ID: 17688075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of three doses of omeprazole in the treatment of equine gastric ulcer syndrome: A blinded, randomised, dose-response clinical trial.
    Sykes BW; Sykes KM; Hallowell GD
    Equine Vet J; 2015 May; 47(3):285-90. PubMed ID: 24761780
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Relative bioavailability and pharmacokinetic comparison of two different enteric formulations of omeprazole.
    Liu J; Shentu JZ; Wu LH; Dou J; Xu QY; Zhou HL; Wu GL; Huang MZ; Hu XJ; Chen JC
    J Zhejiang Univ Sci B; 2012 May; 13(5):348-55. PubMed ID: 22556172
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A relative bioavailability study of 2 oral formulations of omeprazole after their administration in repeated doses to healthy volunteers].
    Richards JP; Gimeno M; Moreland TA; McEwen J
    Gastroenterol Hepatol; 1999 Apr; 22(4):171-5. PubMed ID: 10349786
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetic and pharmacodynamic effects of 2 registered omeprazole preparations and varying dose rates in horses.
    Wise JC; Hughes KJ; Edwards S; Jacobson GA; Narkowicz CK; Raidal SL
    J Vet Intern Med; 2021 Jan; 35(1):620-631. PubMed ID: 33340169
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect on bioavailability of admixing the contents of lansoprazole capsules with selected soft foods.
    Chun AH; Erdman K; Zhang Y; Achari R; Cavanaugh JH
    Clin Ther; 2000 Feb; 22(2):231-6. PubMed ID: 10743982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lack of pharmacokinetic interaction between omeprazole or lansoprazole and ivabradine in healthy volunteers: an open-label, randomized, crossover, pharmacokinetic interaction clinical trial.
    Portolés A; Calvo A; Terleira A; Laredo L; Resplandy G; Gorostiaga C; Moreno A
    J Clin Pharmacol; 2006 Oct; 46(10):1195-203. PubMed ID: 16988209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetics of a new immediate-release compound omeprazole capsule and its comparison with the enteric-coated formulation under fasting and fed conditions.
    Liu Z; Ding L; Zhong S; Cao X; Jiang L; Duan H
    Drug Res (Stuttg); 2013 Jul; 63(7):370-5. PubMed ID: 23558602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential pharmacokinetics of diclofenac potassium for oral solution vs immediate-release tablets from a randomized trial: effect of fed and fasting conditions.
    Chen C; Bujanover S; Kareht S; Rapoport AM
    Headache; 2015 Feb; 55(2):265-75. PubMed ID: 25546369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative bioavailability of two enteric-coated capsules of omeprazole in healthy volunteers.
    Garg SK; Chugh Y; Tripathi SK; Kumar N; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1993 Feb; 31(2):96-9. PubMed ID: 8458683
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and tolerance of pantoprazole, a proton pump inhibitor after single and multiple oral doses in healthy Japanese volunteers.
    Tanaka M; Yamazaki H; Ryokawa Y; Hakusui H; Nakamichi N; Sekino H
    Int J Clin Pharmacol Ther; 1996 Oct; 34(10):415-9. PubMed ID: 8897077
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.